NO144468C - Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent - Google Patents

Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent

Info

Publication number
NO144468C
NO144468C NO763446A NO763446A NO144468C NO 144468 C NO144468 C NO 144468C NO 763446 A NO763446 A NO 763446A NO 763446 A NO763446 A NO 763446A NO 144468 C NO144468 C NO 144468C
Authority
NO
Norway
Prior art keywords
dry
procedure
preparation
solid substance
substance containing
Prior art date
Application number
NO763446A
Other languages
English (en)
Other versions
NO144468B (no
NO763446L (no
Inventor
Lothar Ehrhardt
Volker Hartmann
Karl-Heinz Otto
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO763446L publication Critical patent/NO763446L/no
Publication of NO144468B publication Critical patent/NO144468B/no
Publication of NO144468C publication Critical patent/NO144468C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO763446A 1975-10-17 1976-10-08 Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent NO144468C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (3)

Publication Number Publication Date
NO763446L NO763446L (no) 1977-04-19
NO144468B NO144468B (no) 1981-06-01
NO144468C true NO144468C (no) 1981-09-09

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763446A NO144468C (no) 1975-10-17 1976-10-08 Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent

Country Status (28)

Country Link
JP (1) JPS5854122B2 (no)
AT (1) AT362510B (no)
AU (1) AU508628B2 (no)
BE (1) BE847368A (no)
CA (1) CA1079641A (no)
CH (1) CH643737A5 (no)
CS (1) CS199647B2 (no)
DE (1) DE2546577B2 (no)
DK (1) DK146194C (no)
ES (1) ES452420A1 (no)
FI (1) FI762875A (no)
FR (1) FR2327764A1 (no)
GB (1) GB1560406A (no)
GR (1) GR61268B (no)
HK (1) HK3183A (no)
HU (1) HU172533B (no)
IE (1) IE43778B1 (no)
IL (1) IL50686A (no)
MY (1) MY8400063A (no)
NL (1) NL184558C (no)
NO (1) NO144468C (no)
NZ (1) NZ182341A (no)
PH (1) PH14513A (no)
PT (1) PT65719B (no)
SE (1) SE430379B (no)
SG (1) SG63082G (no)
SU (1) SU1165223A3 (no)
ZA (1) ZA766166B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
DE69821984T2 (de) * 1997-12-22 2004-12-30 Schering Corp. Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
KR100504618B1 (ko) * 1999-12-03 2005-08-04 폴리켐 에스.아. 향상된 생체 이용율을 갖는 에르고트 알칼로이드의 서방형약제학적 조성물의 제조방법 및 그들의 조성물
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
DE60309356T2 (de) * 2003-06-27 2007-08-30 Bioprogress S.P.A. Zusammensetzung, durch zusammen vermahlen eines wirkstoffes mit einem n-vinyl-2-pyrrolidon/vinylacetatkopolymers erhältlich

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
HK3183A (en) 1983-01-20
DK454176A (da) 1977-04-18
IE43778B1 (en) 1981-05-20
DK146194C (da) 1984-01-02
GR61268B (en) 1978-10-17
PT65719A (fr) 1976-11-01
IL50686A0 (en) 1976-12-31
IE43778L (en) 1977-04-17
HU172533B (hu) 1978-09-28
ZA766166B (en) 1978-05-30
SE430379B (sv) 1983-11-14
SU1165223A3 (ru) 1985-06-30
NO144468B (no) 1981-06-01
IL50686A (en) 1979-05-31
JPS5251014A (en) 1977-04-23
CH643737A5 (en) 1984-06-29
PH14513A (en) 1981-08-24
FR2327764A1 (fr) 1977-05-13
ES452420A1 (es) 1978-04-16
FI762875A (no) 1977-04-18
ATA767976A (de) 1980-10-15
NL184558B (nl) 1989-04-03
CA1079641A (en) 1980-06-17
NL7611295A (nl) 1977-04-19
CS199647B2 (en) 1980-07-31
DE2546577A1 (de) 1977-04-21
SG63082G (en) 1983-09-09
JPS5854122B2 (ja) 1983-12-02
DK146194B (da) 1983-07-25
NZ182341A (en) 1978-09-20
NL184558C (nl) 1989-09-01
AU1875476A (en) 1978-04-20
AU508628B2 (en) 1980-03-27
GB1560406A (en) 1980-02-06
FR2327764B1 (no) 1979-03-02
MY8400063A (en) 1984-12-31
NO763446L (no) 1977-04-19
DE2546577B2 (de) 1981-04-02
SE7611189L (sv) 1977-04-18
PT65719B (fr) 1978-06-12
BE847368A (fr) 1977-04-15
AT362510B (de) 1981-05-25

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
DK484876A (da) Fremgangsmade til fremstilling af 2-phenyl-3-aroylbenzothiophener og -thiophen-1-oxider
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
NO144209C (no) Fremgangsmaate for fremstilling av dialkylkarbonater
SE426944B (sv) Forfarande for framstellning av alkylenkarbonater
NO144468C (no) Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
SE433937B (sv) Forfarande for framstellning av penicillinestrar
AR211273A1 (es) Procendimiento de preparacion de nuevas (fenoxi-4-fenil)1-piperazinas
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE7607786L (sv) Forfarande for framstellning av sulfamylbensylforeningar
SE443142B (sv) Forfarande for framstellning av rifamycinforeningar
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
DK143946C (da) Fremgangsmaade til fremstilling af et vaskepulver
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
NO144739C (no) Fremgangsmaate for fremstilling av presset torvsubstrat
SE7600754L (sv) Forfarande for framstellning av svavelinnehallande oktapeptidderivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner